Has Sara Khaled received payments from drug or device companies?

Yes. Drug and device makers reported $1,621 in general payments to Sara Khaled across 68 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sara Khaled did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sara Khaled come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sara Khaled

Family · Chandler, AZNPI 1962077024

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 43.9% of the total. Reporting peaked in 2022 at $865 and has fallen 79.5% since, to $177 in 2025.

$1,621in general payments, 2019–2025

Across 68 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$712
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$197
Mallinckrodt Hospital Products Inc.$94
Dynavax Technologies Corporation$89
Sanofi$60
Exact Sciences$54
plus $416 from 14 others

What the payments were for

Food & beverage$1,621100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	23	$712
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	10	$197
Mallinckrodt Hospital Products Inc.	3	$94
Dynavax Technologies Corporation	6	$89
Sanofi	3	$60
Exact Sciences	3	$54
Regeneron Healthcare Solutions, Inc.	2	$53
Takeda Pharmaceuticals U.S.A., Inc.	2	$48
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$38
Ferring Pharmaceuticals Inc.	2	$38
Intercept Pharmaceuticals, Inc.	2	$36
W. L. Gore & Associates, Inc.	2	$29
Johnson & Johnson	1	$26
Ipsen Biopharmaceuticals, Inc	1	$25
Renalytix AI, Inc.	1	$25
Ardelyx, Inc.	1	$22
Almatica Pharma LLC	1	$21
Redhill Biopharma Inc.	1	$19
Novo Nordisk	1	$18
GSK	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Creon$105
Skyrizi$104
Rinvoq$104

How this compares

$1,621 in reported general payments places this provider in the 75th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona →

Other family in Chandler

Mia ChorneyChandler$79K
Simon ParkinsonChandler$40K
Anjanette KibbyChandler$21K
Courtney BrzyckiChandler$14K
Sharon MagalonaMesa$441K
Angela GoldenMunds Park$378K
Kimberly HallaPhoenix$332K
Kaitlyn LouchheimScottsdale$208K
Rebecca McCollaumMesa$149K
Lindsay CarterTucson$108K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →